Avecho Biotechnology Limited (ASX:AVE)
Australia flag Australia · Delayed Price · Currency is AUD
0.0100
+0.0010 (11.11%)
At close: Mar 4, 2026

Avecho Biotechnology Balance Sheet

Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4.662.375.51.473.26
Cash & Short-Term Investments
4.662.375.51.473.26
Cash Growth
96.40%-56.86%274.90%-55.03%74.33%
Accounts Receivable
0.160.57--0.04
Other Receivables
2.051.681.10.751.09
Receivables
2.22.251.10.751.13
Inventory
0.010.140.10.40.2
Prepaid Expenses
---0.230.22
Other Current Assets
0.180.050.30.01-
Total Current Assets
7.064.8172.854.81
Property, Plant & Equipment
0.030.170.320.470.34
Other Intangible Assets
---0.030.1
Other Long-Term Assets
0.020.02---
Total Assets
7.1157.323.355.25
Accounts Payable
0.10.060.090.190.08
Accrued Expenses
0.560.560.490.460.42
Short-Term Debt
-0.98---
Current Portion of Leases
0.010.080.080.070.08
Current Unearned Revenue
--0.16--
Other Current Liabilities
0.030.020.020.020.12
Total Current Liabilities
0.711.710.840.750.7
Long-Term Leases
-0.010.10.180.01
Long-Term Unearned Revenue
4.83----
Other Long-Term Liabilities
00---
Total Liabilities
5.551.730.940.920.71
Common Stock
246.9244.61244.61237.53237.6
Retained Earnings
-273.81-269.39-267.44-264.1-262.07
Comprehensive Income & Other
28.4728.0629.212929
Shareholders' Equity
1.563.276.382.424.54
Total Liabilities & Equity
7.1157.323.355.25
Total Debt
0.011.080.180.250.09
Net Cash (Debt)
4.651.35.331.223.17
Net Cash Growth
258.21%-75.65%336.06%-61.46%85.80%
Net Cash Per Share
0.000.000.000.000.00
Filing Date Shares Outstanding
3,6733,1693,1691,8381,838
Total Common Shares Outstanding
3,6733,1693,1691,8381,836
Working Capital
6.353.16.162.114.11
Book Value Per Share
0.000.000.000.000.00
Tangible Book Value
1.563.276.382.44.43
Tangible Book Value Per Share
0.000.000.000.000.00
Machinery
----0.55
Leasehold Improvements
----0.2
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.